OPTIMAL TIMING OF LETERMOVIR PROPHYLAXIS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: INSIGHTS FROM A REAL-WORLD TIME-VARYING EXPOSURE ANALYSIS (EBMT 2026) - Mar 14, 2026 - Abstract #B119; Pres time: Mar 24, 2026; 06:00 PM - 07:00 PM; Location: VELAZQUEZ; "Our real-world analysis suggests that initiating LTV prophylaxis within 14 days and discontinuing between days 119 and 139 post-transplantation provides optimal protection against csCMVi."
Clinical • Real-world • Real-world evidence • Bone Marrow Transplantation • Cytomegalovirus Infection • Hematological Disorders • Infectious Disease • Transplantation
|
|
Xueyao Li1; Yigeng Cao1; Wenhao Wang2,1; Ruixin Li1; Erlie Jiang1
|